Fabrice Egros - Net Worth and Insider Trading
Fabrice Egros Net Worth
The estimated net worth of Fabrice Egros is at least $315,040 dollars as of 2024-11-06. Fabrice Egros is the Director of Syndax Pharmaceuticals Inc and owns about 16,000 shares of Syndax Pharmaceuticals Inc (SNDX) stock worth over $315,040. Details can be seen in Fabrice Egros's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Fabrice Egros has not made any transactions after 2021-11-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Fabrice Egros
Fabrice Egros Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Fabrice Egros owns 1 companies in total, including Syndax Pharmaceuticals Inc (SNDX) .
Click here to see the complete history of Fabrice Egros’s form 4 insider trades.
Insider Ownership Summary of Fabrice Egros
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SNDX | Syndax Pharmaceuticals Inc | 2021-11-18 | director |
Fabrice Egros Latest Holdings Summary
Fabrice Egros currently owns a total of 1 stock. Fabrice Egros owns 16,000 shares of Syndax Pharmaceuticals Inc (SNDX) as of November 18, 2021, with a value of $315,040.
Latest Holdings of Fabrice Egros
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SNDX | Syndax Pharmaceuticals Inc | 2021-11-18 | 16,000 | 19.69 | 315,040 |
Holding Weightings of Fabrice Egros
Fabrice Egros Form 4 Trading Tracker
According to the SEC Form 4 filings, Fabrice Egros has made a total of 4 transactions in Syndax Pharmaceuticals Inc (SNDX) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Syndax Pharmaceuticals Inc is the sale of 14,030 shares on November 18, 2021, which brought Fabrice Egros around $252,961.
Insider Trading History of Fabrice Egros
- 1
Fabrice Egros Trading Performance
Fabrice Egros Ownership Network
Ownership Network List of Fabrice Egros
Ownership Network Relation of Fabrice Egros
Fabrice Egros Owned Company Details
What does Syndax Pharmaceuticals Inc do?
Who are the key executives at Syndax Pharmaceuticals Inc?
Fabrice Egros is the director of Syndax Pharmaceuticals Inc. Other key executives at Syndax Pharmaceuticals Inc include Chief Financial Officer Keith A. Goldan , director & Chief Executive Officer Briggs Morrison , and President & Head of R&D Neil Gallagher .
Syndax Pharmaceuticals Inc (SNDX) Insider Trades Summary
Over the past 18 months, Fabrice Egros made no insider transaction in Syndax Pharmaceuticals Inc (SNDX). Other recent insider transactions involving Syndax Pharmaceuticals Inc (SNDX) include a net sale of 211,420 shares made by Briggs Morrison , a net purchase of 673 shares made by Keith A. Goldan , and a net sale of 83,000 shares made by William Meury .
In summary, during the past 3 months, insiders sold 0 shares of Syndax Pharmaceuticals Inc (SNDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 294,997 shares of Syndax Pharmaceuticals Inc (SNDX) were sold and 1,250 shares were bought by its insiders, resulting in a net sale of 293,747 shares.
Syndax Pharmaceuticals Inc (SNDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Syndax Pharmaceuticals Inc Insider Transactions
Fabrice Egros Mailing Address
Above is the net worth, insider trading, and ownership report for Fabrice Egros. You might contact Fabrice Egros via mailing address: C/o Syndax Pharmaceuticals, Inc., Totten Pond Road, Suite 140, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
